Jennifer K. Richer
University of Colorado Denver
H-index: 57
North America-United States
Top articles of Jennifer K. Richer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment | Cancer Immunology, Immunotherapy | Toru Hanamura Kozue Yokoyama Shigehisa Kitano Hiroshi Kagamu Makiko Yamashita | 2024/2/13 |
The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma | bioRxiv | Lucy B Van Kleunen Mansooreh Ahmadian Miriam D Post Rebecca J Wolsky Christian Rickert | 2024 |
Abstract PO1-24-12: Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment | Cancer Research | Toru Hanamura Kozue Yokoyama Shigehisa Kitano Hiroshi Kagamu Makiko Yamashita | 2024/5/2 |
Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression | Cancer Research Communications | Lyndsey S Crump Jessica L Floyd Li-Wei Kuo Miriam D Post Mike Bickerdike | 2024/3/18 |
Abstract PR-010: Dual targeting of IDO1/TDO2 inhibits tumor progression and attenuates the immune suppressive tumor microenvironment | Cancer Research | Lyndsey Crump Jessica Floyd Elizabeth Woodruff Mike Bickerdike Li-Wei Kuo | 2024/3/4 |
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation | Cell systems | Frederick R Adler Alexander RA Anderson Abhinav Bhushan Paul Bogdan Jose Javier Bravo-Cordero | 2023/4/19 |
Abstract CT144: Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2-breast cancer | Cancer Research | Anthony D Elias Alyse Staley Monica Fornier Gregory A Vidal Sharon Sams | 2023/4/14 |
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023 | Thomas P Burris Ian Mitchelle S de Vera Isabelle Cote Colin A Flaveny Udayanga S Wanninayake | 2023/11/1 | |
RUNX1 is regulated by androgen receptor to promote cancer stem markers and chemotherapy resistance in triple negative breast cancer | Cells | Natalia B Fernández Sofía M Sosa Justin T Roberts María S Recouvreux Luciana Rocha-Viegas | 2023/1/29 |
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics | Cancers | Lisa Welter Serena Zheng Sonia Maryam Setayesh Michael Morikado Arushi Agrawal | 2023/8/3 |
Abstract B008: The role of the androgen receptor in reciprocal activation of breast cancer metastases and the lung epithelium during metastatic outgrowth | Cancer Research | Jessica L Christenson Nicole S Spoelstra G Devon Trahan Kathleen I O'Neill Michelle M Williams | 2023/1/15 |
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer | NPJ Breast Cancer | Anthony D Elias Nicole S Spoelstra Alyse W Staley Sharon Sams Lyndsey S Crump | 2023/5/20 |
3C. 3-Ketosteroid receptors in GtoPdb v. 2023.1 | IUPHAR/BPS Guide to Pharmacology CITE | Derek Cain John Cidlowski Dean P Edwards Peter Fuller Sandra L Grimm | 2023/4/26 |
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8+ T Cell Immunity | Cancers | Faye A Camp Tonya M Brunetti Michelle M Williams Jessica L Christenson Varsha Sreekanth | 2022/9/9 |
1421 ELK3 modulates the immune landscape and immune response to natural killer cells in triple negative breast cancers | Joo Dong Park Kwang-Soo Kim Dae-Keum Lee Seung Hee Choi Hae-Yun Jung | 2022/11/1 | |
NPC1 confers metabolic flexibility in triple negative breast cancer | Cancers | Kathleen I O’Neill Li-Wei Kuo Michelle M Williams Hanne Lind Lyndsey S Crump | 2022/7/21 |
The underappreciated role of resident epithelial cell populations in metastatic progression: contributions of the lung alveolar epithelium | Jessica L Christenson Michelle M Williams Jennifer K Richer | 2022/12/1 | |
Abstract PD1-08: Esr1 mutant breast cancers show elevated basal cytokeratins and immune activation | Cancer Research | Zheqi Li Yang Wu Olivia Mcginn Amir Bahreini Nolan M Priedigkeit | 2022/2/15 |
Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer | NPJ Breast Cancer | Zheqi Li Nicole S Spoelstra Matthew J Sikora Sharon B Sams Anthony Elias | 2022/5/10 |
Revealing Molecular Mechanisms Supporting Trophoblast-Mediated Maternal Immune Tolerance | Endocrinology | Michelle M Williams Jennifer K Richer | 2022/8 |
